Neuroprotection of NSC Therapy is Superior to Glibenclamide in Cardiac Arrest-Induced Brain Injury via Neuroinflammation Regulation

The authors evaluated and compared the therapeutic effects of neural stem cell (NSC) and glibenclamide (GBC) therapies post-cardiac arrest. In in vitro studies, BV2 cells underwent oxygen–glucose deprivation for three hours and were then treated with GBC or co-cultured with human NSCs.